Leptin and β2-microglobulin kinetics with three different dialysis modalities

International Journal of Artificial Organs

Volumn 29, Issue 10, 2006, Pages 949-955

  Mandolfo, Salvatore ^a   Borlandelli, S ^a   Imbasciati, E ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

Clearance; Leptin; Rebound; 2m

Indexed keywords

BIOCOMPATIBILITY; BLOOD; DIALYSIS MEMBRANES; HORMONES; KINETICS; NUTRITION; PROTEINS;

% REDUCTIONS; BODY WEIGHT; CLEARANCE; HEMODIAFILTRATION; HIGH FLUX; KIDNEY FUNCTION; LEPTINS; LOW FLUX; REBOUND; Β2M;

DIALYSIS;

BETA 2 MICROGLOBULIN; LEPTIN;

ADIPOCYTE; ADULT; AGED; ARTERIAL BLOOD; ARTICLE; ATHEROSCLEROSIS; BIOCOMPATIBILITY; BLOOD SAMPLING; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLEARANCE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DISEASE ASSOCIATION; FILTER DESIGN; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; MALNUTRITION; MEMBRANE FILTER; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MOLECULAR WEIGHT; PREDICTION; PROTEIN BINDING; PROTEIN SYNTHESIS; TREATMENT OUTCOME; UREMIA; VENOUS BLOOD; BLOOD; COMPARATIVE STUDY; FEMALE; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

AGED; BETA 2-MICROGLOBULIN; FEMALE; HUMANS; KIDNEY FAILURE; LEPTIN; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 33845910401     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602901005     Document Type: Article

References (31)

1. Zhang Y, Proenca R, Maffei M, Barone M, Lori L, Friedman JM. Positional cloning of the mouse ob gene and its human homologue. Nature 1994; 372: 425-32.
2. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes 1998; 22: 1145-58.
3. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052-6.
4. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997; 82: 847-50.
5. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BR, Kurnik PB, O'Connor J, Sinha M, Caro JF. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997; 51: 1980-5.
6. Nakazono H, Nagake Y, Ichikawa H, Makino H. Serum leptin concentrations in patients on hemodialysis. Nephron 1998; 80: 35-40.
7. Nishikawa M, Takagi T, Yoshikawa N, Shouzu A, Murakami T, Kono M, Owae H, Tanaka K, Iwasaka T, Inada M. Measurement of serum leptin in patients with chronic renal failure on hemodialysis. Clin Nephrol 1999; 51: 296-303.
8. Stenvinkel P. Leptin - a new hormone of definite interest for the nephrologist. Nephrol Dial Transplant 1998; 13: 1099-101.
9. Stenvinkel P, Lonnqvist F, Schalling M. Molecular basis of renal disease. Molecular studies of leptin: implications for renal disease. Nephrol Dial Transplant 1999; 14: 1103-12.
10. Bossola M, Muscaritoli M, Valenza V, Panocchia N, Tazza L, Cascino A, Laviano A, Liberatori M, Moussier M, Fanelli FR, Luciani G. Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract 2004; 97: 76-82.
11. Boenisch O, Ehmke KD, Heddergott A, Naoum C, Frei U, Schindler R. C-reactive-protein and cytokine plasma levels in hemodialysis patients. J Nephrol 2002; 15: 547-51.
12. Ottonello L, Gnerre P, Bertolotto M, Mancini M, Dapino P, Russo R, Garibotto G, Barreca T, Dallegri F. Leptin as a uremic toxin interferes with neutrophil chemotaxis. J Am Soc Nephrol 2004; 15: 2366-72.
13. Vanholder R, De Smet R, Glorieux R, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group (EUTox). Review on uremic toxin: classification, concentration and interindividual variability. Kidney Int 2003; 63; 1934-43.
14. Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R. Intradialytic removal of protein bound uremic toxin: role of solute characteristics and of dialyzer membranes. Nephrol Dial Transplant 2000; 15: 50-7.
15. Wright MJ, Woodrow G, Young G, Brownjohn AM, Turney JH. Biocompatible dialysis membranes do not reduce plasma leptin levels. Nephrol Dial Transplant 2000; 15: 925-6.
16. Coyne DW, Dagogo-Jack S, Klein S, Merabet E, Audrain J, Landt M. High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients. Am J Kidney Dis 1998; 32: 1031-5.
17. van Tellingen A, Grooteman MP, Schoorl M, ter Wee PM, Bartels PC, Schoorl M, van der Ploeg T, Nube MJ. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialyzers. Nephrol Dial Transplant 2004; 19: 1198-203.
18. Bammens B, Evenepoel P. Improving removal of protein-bound retentions solutes. Contrib Nephrol 2005; 149: 175-84.
19. Beerenhout CH, Luik AJ, Jeuken-Mertens SG, Bekers O, Menheere P, Hover L, Klaassen L, van der Sande FM, Cheriex EC, Meert N, Leunissen KM, Kooman JP. Predilution on-line haemofiltration vs. low-flux haemodialysis: a randomized prospective study. Nephrol Dial Transplant 2005; 20: 1155-63.
20. Bergstrom J, Wehle B. No change in corrected beta 2-microglobulin concentration after cuprophane hemodialysis. Lancet 1987; 1: 628-9.
21. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-7.
22. Stenvinkel P. Leptin and blood pressure - is there a link? Nephrol Dial Transplant 2000; 15: 1115-7.
23. Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Cheni JB. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. Int J Artif Organs 2004; 27: 835-41.
24. Zoccali C, Panuccio V, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Leptin and biochemical markers of bone turnover in dialysis patients. J Nephrol 2004; 17: 253-60.
25. Widjaja A, Kielstein JT, Horn R, von zur Mühlen A, Kliem V, Brabant G. Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease. Nephrol Dial Transplant 2000; 15: 846-50.
26. Ward RA. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application? J Am Soc Nephrol 2005; 16: 2421-30.
27. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section II. Haemodialysis adequacy (Part 1). Haemodialysis dose quantification: middle molecules. Nephrol Dial Transplant 2002; 17 (Suppl 7): 21-3.
28. Leypoldt JK, Cheung AK, Deeter RB, Goldfarb-Rumyantzev A, Greene T, Depner TA, Kusek J. Kinetics of urea and 2-microglobulin during and after short hemodialysis treatments. Kidney Int 2004; 66: 1669-76.
29. Gotch F, Levin N, Zasuwa G, Tayeb J. Kinetics of beta-2-microglobulin in hemodialysis. Contrib Nephrol 1989; 74: 132-8.
30. Lian JD, Cheng CH, Chang YL, Hsiong CH, Lee CJ. Clinical experience and model analysis on beta-2-microglobulin kinetics in high-flux hemodialysis. Artif Organs 1993; 17: 758-63.
31. Leypoldt JK, Cheung AK, Deeter RB. Rebound kinetics of beta-2-microglobulin after hemodialysis. Kidney Int 1999; 56: 1571-7.